The Enterprise Value as of November 2024 (TTM) for Aptinyx Inc. (APTX) is -13266343.00

According to Aptinyx Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -13266343.00. This represents a change of -12.82% compared to the average of -15217413.10 of the last 4 quarters.

Aptinyx Inc. (APTX) Historical Enterprise Value (quarterly & annually)

How has APTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Aptinyx Inc. over the last ten years is 176.04M. The current -13266343.00 Enterprise Value has changed -853.59% with respect to the historical average. Over the past ten years (40 quarters), APTX's Enterprise Value was at its highest in in the September 2018 quarter at 787.34M. The Enterprise Value was at its lowest in in the March 2020 quarter at -26336400.00.

Aptinyx Inc. (APTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aptinyx Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aptinyx Inc. (APTX) Average Enterprise Value

How has APTX Enterprise Value performed in the past?

The current Enterprise Value of Aptinyx Inc. (APTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aptinyx Inc. (APTX) Enterprise Value vs. Peers

How is APTX’s Enterprise Value compared to its peers?

Aptinyx Inc.’s Enterprise Value is less than Evelo Biosciences, Inc. (16.69M), greater than Magenta Therapeutics, Inc. (-114170976.00), less than Aileron Therapeutics, Inc. (64.72M), less than ABVC BioPharma, Inc. (9.84M), less than Neoleukin Therapeutics, Inc. (-6333315.00), less than CytomX Therapeutics, Inc. (47.40M), less than Assembly Biosciences, Inc. (90.29M), less than Instil Bio, Inc. (258.54M), less than Nuvation Bio Inc. (1.02B), greater than Allarity Therapeutics, Inc. (-15916163.00), less than NeuroBo Pharmaceuticals, Inc. (-6292396.00), less than Hillstream BioPharma, Inc. (1.48M), less than Virax Biolabs Group Limited (5.49M), less than Quoin Pharmaceuticals, Ltd. (3.24M), less than Spero Therapeutics, Inc. (11.13M), greater than Achilles Therapeutics plc (-48532901.00), less than Adial Pharmaceuticals, Inc. (3.15M), less than TransCode Therapeutics, Inc. (5.76M), less than Aditxt, Inc. (12.23M), less than Reviva Pharmaceuticals Holdings, Inc. (28.64M), less than Avenue Therapeutics, Inc. (-1770008.00),

Build a custom stock screener for Aptinyx Inc. (APTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptinyx Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptinyx Inc. (APTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptinyx Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.